Bio-responsive chitin-poly(l-lactic acid) composite nanogels for liver cancer

- We developed injectable Dox-chitin-PLA CNGs for liver cancer.
- Chitin-PLA CNGs showed controlled swelling and degradation and non-hemolytic.
- Chitin-PLA CNGs showed sustained drug release of Dox.
- Dox-chitin-PLA CNGs showed dose dependent cytotoxicity toward HepG2 cells.